trontinemab

Roche unveils trial to prevent Alzheimer’s before symptoms appear

Roche has revealed the design of PrevenTRON, a Phase III trial that will test whether its experimental drug trontinemab can prevent Alzheimer's disease in people who show no cognitive symptoms but carry biological markers of the illness. The study design…